Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
XG Y-linked 1 (XGY1), also referenced as XGPY1, is a naturally truncated pseudogene on the human Y chromosome derived from duplication of the XG gene in the primate lineage. It is thought to be transcribed, but there is no evidence of a functional protein product or involvement in therapeutic pathways[3][4][6]. This gene is annotated as a pseudogene and not as a receptor, enzyme, transporter, or any classical molecule type of interest for drug targeting[3][6]. As such, it is not considered a therapeutic target, nor is it associated with known biological functions, disease relevance, or drug interactions. The available scientific literature does not describe any actionable safety concerns, disease roles, or use as a biomarker. If you are seeking information about a therapeutic target, this entry is incorrect for drug discovery or biological function mapping.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on XG Y-linked 1 pseudogene (XGY1).